Skip to main content

Scynexis Inc

SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001178253

No open-market purchases or sales by Scynexis Inc insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Scynexis Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of SCYX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4144+3
Shares16.3M16.3M−35.5K (−0.2%)
Value$30.5M$39.1M+$8.55M (+28.0%)

New holders (7)

Institutions that held Scynexis Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to SCYX in Q3 2022
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP44,802$108.0K0.00%
Virtu Financial LLC31,801$76.0K0.01%
Magnus Financial Group LLC30,000$72.0K0.01%
Dimensional Fund Advisors LP17,006$41.0K0.00%
Park Avenue Securities LLC14,000$34.0K0.00%
Royal Bank of Canada154$00.00%
Northwestern Mutual Wealth Management Co87$00.00%

Sold out (4)

Institutions that held Scynexis Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of SCYX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Alyeska Investment Group, L.P.150,000$279.0K
Brandywine Global Investment Management, LLC96,546$180.0K
Walleye Capital LLC23,998$45.0K
Private Advisor Group, LLC20,000$37.0K